Empamax M Sustained Release Tablet 25/1000 mg (Empagliflozin, Metformin)

Adult dose

The dosage of this medication is determined based on the individual patient's current treatment regimen, effectiveness, and tolerance, not exceeding Empagliflozin 25 mg and sustained-release Metformin Hydrochloride 2000 mg. This medication is taken with meals once daily in the evening to reduce gastrointestinal adverse reactions associated with Metformin. The 10/1000 mg or 25/1000 mg sustained-release tablet is taken as 1 tablet once daily.

This medication is used to treat diabetes and has a blood sugar-lowering effect. However, it can rarely cause serious side effects such as lactic acidosis, so caution is required regarding this symptom. Lactic acidosis can manifest as muscle pain, weakness, breathing difficulties, and abdominal pain, and if these symptoms occur, medical consultation should be sought immediately. Additionally, this medication may increase the risk of hypoglycemia when taken with insulin or sulfonylureas, so dosage adjustments may be needed. Patients with impaired kidney function or those with acute infections, dehydration, heart failure, or acute myocardial infarction should not use this medication. In particular, this medication should be temporarily discontinued before and after tests involving iodinated contrast agents, and therapy should be resumed only after kidney function has been confirmed to be normal. It is advisable for pregnant women or those who may become pregnant and patients with liver function disorders to avoid using this medication. During treatment with this medication, urinary or genital infections may occur, and prompt treatment is necessary if symptoms of infection arise. Caution should be taken for elderly patients or those at risk for dehydration regarding fluid loss. Additionally, vitamin B12 levels may decrease, so regular testing is recommended if necessary. Alcohol consumption may increase the risk of lactic acidosis, so drinking alcohol should be avoided. In cases of surgery or severe illness, this medication should be temporarily discontinued and resumed only after the condition stabilizes. This medication should be swallowed whole and not crushed or chewed, although the tablet coating may pass in stool, which is normal. Serious side effects may occur in cases of overdose, so prescribed dosages should be adhered to, and any unusual symptoms should prompt immediate medical attention. Lastly, it should be stored out of reach of children and kept in its original container for safety.

Serious side effects

Hives, severe swelling (angioedema), chest tightness, difficulty breathing, lactic acidosis, ketoacidosis, urosepsis, pyelonephritis, perineal necrosis, severe allergic reactions, severe skin reactions, severe swelling or urination abnormalities, liver abnormalities (jaundice), sudden and severe headaches, stroke, myocardial infarction, serious neurological symptoms, respiratory problems

Mild side effects

• Hypoglycemia
• urinary tract infections
• genital infections
• increased urination
• nausea
• vomiting
• diarrhea
• abdominal pain
• loss of appetite
• constipation

This medication should be stored in a sealed container to protect it from air and moisture. It is advisable to maintain the storage temperature between 1 to 30 degrees Celsius to preserve the medication's effectiveness and safety.

Appearance

Dark pink oval sustained-release film-coated tablet

Package unit

30 tablets/bottle